The company’s revenue reached $112.03 billion, outperforming analyst expectations of $110.85 billion. CFO Wayne DeVeydt noted that while medical costs remain higher than historical norms, the insurer is actively pushing those numbers down through disciplined contract exits and a streamlined operational model. This financial rebound follows a period of significant volatility and an internal executive shake-up aimed at stabilizing margins.
A central pillar of the strategy involves integrating AI to automate prior authorizations and detect fraud, though DeVeydt clarified that these tools do not make clinical decisions on care approval. Despite the earnings success, the insurer faces a shrinking footprint; membership dropped by 525,000 in the second quarter. The company expects further declines in 2026, anticipating a loss of 500,000 exchange members and 1.1 million Medicare Advantage participants as higher premiums, necessitated by rising care costs, pressure affordability. The medical benefit ratio improved to 86.7%, beating the 88.5% expected by Wall Street.



Comments (0)
No comments yet. Be the first!